A detailed history of Souders Financial Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Souders Financial Advisors holds 5,875 shares of BMY stock, worth $317,015. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,875
Previous 6,830 13.98%
Holding current value
$317,015
Previous $370,000 34.32%
% of portfolio
0.04%
Previous 0.06%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 28, 2024

SELL
$40.25 - $52.99 $38,438 - $50,605
-955 Reduced 13.98%
5,875 $243,000
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $327,703 - $371,552
6,830 New
6,830 $370,000
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $110,106 - $123,116
1,902 Added 44.74%
6,153 $357,000
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $2.27 Million - $2.52 Million
-35,620 Reduced 89.34%
4,251 $271,000
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $46,194 - $52,394
703 Added 1.79%
39,871 $2.76 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $79,710 - $94,388
1,164 Added 3.06%
39,168 $2.82 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $119 - $70,769
921 Added 2.48%
38,004 $2.7 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $2.69 Million - $2.97 Million
37,083 New
37,083 $2.86 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Souders Financial Advisors Portfolio

Follow Souders Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.